Question to the Department of Health and Social Care:

To ask the Secretary of State for Health, what the timetable is for the Ticagrelorte drug to be available on the NHS to reduce the risk of fatal heart attacks.

The National Institute for Health and Care Excellence (NICE) published final technology appraisal guidance in December 2016 recommending ticagrelor, in combination with aspirin, for preventing atherothrombotic events in adults who had a myocardial infarction and who are at high risk of a further event. National Health Service commissioners are legally required to make funding available for treatments recommended by NICE within three months of the publication of final guidance.